Respiratory Infections News

Severe COVID-19 was associated with ophthalmological manifestations in more than one-third of patients who presented to a single center with the disease, according to a study published in Retina.

There was a 20% decline in reported cases of tuberculosis in the United States in 2020 compared with previous years, which was not a result of underreporting but did raise concerns that TB was underdiagnosed, researchers said.

In this video, Amesh A. Adalja, MD, a senior scholar in the Johns Hopkins Center for Health Security, describes his experiences during the first months of the COVID-19 pandemic in 2020.

Moderna announced that it is seeking an emergency use authorization from the FDA for an additional booster dose of its COVID-19 vaccine for all adults.

What started as an outbreak of viral pneumonia that infected dozens of people in a city in central China has grown into a pandemic that has killed nearly one million people in the United States alone.

Pfizer and BioNTech announced this week that they are seeking an emergency use authorization from the FDA for an additional booster dose of their COVID-19 vaccine for older adults.

The CDC’s wastewater surveillance tracker shows that 165 U.S. sites have experienced an increase in SARS-CoV-2 levels in the last 15 days.

Surveillance data continue to show that COVID-19 hospitalizations among young children increased fivefold during the omicron wave of SARS-CoV-2 compared with the peak of the delta wave, researchers reported in MMWR.

The incidence of subclinical tuberculosis among people with HIV in a South African study was similar to the incidence of clinical TB, suggesting that guidelines recommending symptom-based screening may need to be updated, researchers said.

Select pharmacies will soon be able to provide antivirals to patients who test positive for SARS-CoV-2 on the spot at no cost through the recently announced test-to-treat initiative.